Q2 2026 actual total revenue vs ~$34M guide
קריטי ספקית מצעי מוליכים-למחצה (InP, GaAs, Ge); InP הוא המנוע — חיבוריות אופטית במרכזי נתונים של AI.
צוואר-בקבוק חומרים ל-AI אופטי — עובד אם כושר InP מוסמך הופך להכנסה מורשית ורווחית.
- מצב התזה
- תזת הביקוש התחזקה; ביצוע/גאופוליטיקה לא פתורים; רגישה-לולואציה.
- תפקיד בתיק
- פוזיציית צוואר-בקבוק חומרים ל-AI אופטי: פוטנציאל גבוה / סיכון גבוה.
- מסגרת פעולה
- החזקה / מעקב (Hold / Monitor)
- טריגר לסקירה
- הכנסת InP/סך ברבעון, מרווח ורווחיות; עדכון אישורי ייצוא/צבר; מאזן אחרי ההנפקה; אבני-דרך קיבולת/Casela.
- גישת הערכה
- Scenario-based; no single price target
מצריך סקירה אנושית שווי / משקל: לא מחושב
מה חייב לקרות
- Export permits become reliable enough to ship demand
- Reported backlog converts into permitted, profitable InP revenue
- Capacity expansion is utilized, with adequate yield and 6-inch progress
- Gross margin expands durably with InP mix and scale
- Post-offering dilution and Tongmei economics do not impair per-share value
מה יכול לשבור את התזה
- Export permits block material shipments for multiple quarters
- Backlog fails to convert or proves low quality
- InP revenue stalls despite downstream demand
- Gross margin falls below 25% without a credible recovery
- Capacity or 6-inch execution fails or stays underutilized
- Coherent, Sumitomo or Chinese suppliers materially displace AXT
- Additional dilution or Tongmei economics impair per-share value
- Architecture shifts materially reduce merchant InP intensity
- Valuation remains premium while evidence weakens
הקטליסטים הבאים
Q2 2026 actual InP revenue vs >$17M outlook
קריטי Additional InP export permits improve shipment reliability
קריטי Official backlog disclosure and conversion
קריטי Q2/Q3 gross margin sustains above 30% toward 35% target
קריטי Filing reconciles post-offering cash, debt, net proceeds and diluted shares
גבוה הסיכונים המרכזיים
China export permits remain unreliable or materially delayed
Valuation prices in growth before revenue, margin and cash-flow proof
InP demand fails to convert into AXTI revenue and economics
Sumitomo, Coherent or Chinese producers expand competitive supply
Reported backlog is cancellable, double-ordered or shortage-inflated
Dilution or capital allocation weakens per-share returns
Tongmei / noncontrolling-interest economics reduce value to AXTI common holders
KPI למעקב
- FY2025 revenue
- $88.326M — down 11.1%; depressed base
- Q1 2026 revenue
- $26.924M — +39.1% YoY
- Q1 2026 InP revenue
- $13.6M — over half of total; primarily data-center related per management
- Q1 2026 GAAP gross margin
- 29.6% — target of 35%-40% not yet achieved
- Q1 2026 GAAP net loss attributable to AXT
- $(1.620)M
- Reported InP backlog
- >$100M — Partially Verified; terms and conversion unverified
- Q2 2026 guide
- ~$34M revenue / >$17M InP — management guidance; not realized
- April 2026 offering
- ~$632.5M gross / ~9.844M shares — funds capacity + 6-inch R&D; materially increases share count
- Q1 China / North America revenue
- 61% / 1% — geographic concentration
כללי פעולה — מסגרת, לא המלצה
הוספה (Add)
- Only when execution evidence strengthens or valuation resets without thesis deterioration
החזקה (Hold)
- While demand is intact and conversion evidence is progressing but incomplete
קיצוץ (Trim)
- When valuation or position size outruns revenue, margin and competitive proof
יציאה (Exit)
- When AXTI-specific conversion breaks; do not rely on category demand alone
שאלות פתוחות
Official Q2/Q3 total and InP revenue, gross margin and profitability vs guidance
קריטי Backlog terms, concentration, permit status and conversion
קריטי Permit cadence by product, customer, geography, volume and duration
קריטי Capacity, utilization, yield, capex and 6-inch InP qualification
גבוה Product-level gross margin and normalized operating leverage
גבוה Post-offering cash, fully diluted shares and Tongmei/common-shareholder economics
גבוה Coherent sourcing after internal ramp; Sumitomo and Chinese external supply
גבוה Structural demand vs shortage, double ordering and pricing normalization
גבוה Casela prepayments, delivery, margin and capacity-allocation effects
בינוני Revenue and margin assumptions embedded in current valuation
קריטי מקורות בריפו
נתיבים בריפו (מקור האמת) — לעיון, לא קישורים פעילים:
ai-context/company-briefs/axti-he.md companies/axti/dashboard.mdcompanies/axti/thesis.mdcompanies/axti/ic-memo.mdcompanies/axti/risks.mdcompanies/axti/catalysts.mdcompanies/axti/competition.mdcompanies/axti/monitoring/README.mdcompanies/axti/working-notes.md
Derived from companies/axti/ — the repo is the source of truth. No price targets, no buy/sell recommendation. InP demand is not the same as AXTI revenue: the chain requires qualification, permits, capacity, shipment, pricing and margin. Backlog is not revenue. The bottleneck moat is real but geopolitically fragile. Never value AXTI from broad AI/data-center TAM.